We are live on
!
Find out more
PTPI
Petros Pharmaceuticals
PTPI
PTPI
Delisted
PTPI was delisted on the 21st of May, 2025.
Fund managers haven’t disclosed any holdings of PTPI yet.
PTPI Hedge Fund Activity: Q2 2025 in Review
0 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Petros Pharmaceuticals (PTPI) for Q2 2025, worth a combined $0 — down 100% from $77.6K a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of PTPI and 0 opened new positions — a net loss of 14 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Jane Street, exiting entirely with an estimated $38.9K sold.
- 0 institutional investors held Petros Pharmaceuticals (PTPI) as of Q2 2025, down from 14 in Q1 2025.
- Funds reported $0 of Petros Pharmaceuticals stock for Q2 2025, down 100% quarter-over-quarter.
- 0 funds opened new Petros Pharmaceuticals positions in Q2 2025 and 14 closed out, a net change of -14 holders.
- The largest Petros Pharmaceuticals seller in Q2 2025 was Jane Street, an estimated $38.9K sold.
Based on aggregated 13F filings for Q2 2025.